Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Sygkliti‐Henrietta Pelidou"'
Autor:
Marina Boziki, Charis Styliadis, Christos Bakirtzis, Eleni Grigoriadou, Aggeliki-Styliani Sintila, Ioannis Nikolaidis, Aliki Vrienniou, Lotte Geys, Sygkliti-Henrietta Pelidou, Lesley Probert, Georgios Papazisis, Panagiotis Bamidis, Nikolaos Grigoriadis
Publikováno v:
Frontiers in Neurology, Vol 12 (2021)
Background: In the context of the coronavirus disease 2019 (COVID-19) pandemic, the constant needs of people with multiple sclerosis (PwMS) and their caregivers were urgently highlighted.Aim: The present study aims to capture the effects of the COVID
Externí odkaz:
https://doaj.org/article/d2437df8d27c4353a272689fd8fe7900
Autor:
George D. Vavougios, Sygkliti‐Henrietta Pelidou, Thomas Mavromatis, Dimitrios Mandras, Triantafyllos Ntoskas
Publikováno v:
Clinical Case Reports, Vol 8, Iss 6, Pp 955-957 (2020)
Abstract This case illustrates the need to correctly identify oscillopsia among cases of self‐reported dizziness, and ocular flutter itself as a presenting sign of potentially serious underlying disease. The neurologist should approach these patien
Externí odkaz:
https://doaj.org/article/50c995261cb842a0acce90a631d67ef8
Autor:
Theano Tatsi, Anna Kalogera-Fountzila, Lemonia Skoura, Vasiliki Tsavdaridou, Eleni Polyzoidou, Dimitrios Parissis, Eleni Grigoriadou, Virginia Giantzi, Panagiotis Ioannidis, Theodoros Karapanayotides, Roza Lagoudaki, Nikolaos Grigoriadis, Ioannis Nikolaidis, Theodora Afrantou, Pamela Melo, Marina Boziki, Sofia Zoidou, Georgios C. Papadopoulos, Evdoxia Gounari, Nikolaos Mandoras, Christos Bakirtzis, Sygkliti-Henrietta Pelidou
Publikováno v:
Neurological Research. 42:209-221
Objectives: Natalizumab (NTZ), a treatment indicated for patients with highly active Relapsing – Remitting Multiple Sclerosis (RRMS), is known to induce increased relative frequency of lymphocytes. Progressive Multifocal Leukoencephalitis (PML) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aa0932e073456ab527207e5879a3a915
https://doi.org/10.1080/01616412.2020.1722913
https://doi.org/10.1080/01616412.2020.1722913
Autor:
Eleftheria Siarava, Sygkliti-Henrietta Pelidou, Sofia Markoula, Athanassios P. Kyritsis, Thomas Hyphantis
Publikováno v:
Epilepsybehavior : EB. 111
Objective The aim of the present study was to explore the factors related to the severity of the adverse effects of antiepileptic drugs (AEDs), experienced by patients with epilepsy. Materials and methods A case study was conducted in adult patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::52a3b8fcaa7c3c7764ab60426be9c046
https://pubmed.ncbi.nlm.nih.gov/32534420
https://pubmed.ncbi.nlm.nih.gov/32534420
Autor:
Iosif Xidakis, Dimitrios Parisis, Theodoros Karapanayiotides, Nikolaos Grigoriadis, John Elloul, Vasiliki Kostadima, Dimitra Papadimitriou, Marianthi Breza, Elisabeth Chroni, Christos Bakirtzis, Georgios Koutsis, Katerina Karagiorgou, Sygkliti-Henrietta Pelidou, Anastasios Orologas, Ioannis Markakis, Paraskevi Zisimopoulou, Konstantinos Notas, C. Kilidireas, Ioannis Nikolaidis, Maria Anagnostouli, Socrates J. Tzartos, Maria-Eleftheria Evangelopoulos, Thomas Maris, Dimitrios Tzanetakos, John Tzartos
Publikováno v:
Journal of the Neurological Sciences
IgG antibodies to myelin oligodendrocyte glycoprotein (MOG) detected by cell based assays (CBA) have been identified in a constantly expanding spectrum of CNS demyelinating disorders. However, a universally accepted CBA has not been adopted yet. We a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f67c8a0a297fdec2d6d6f11770483c9e
https://pubmed.ncbi.nlm.nih.gov/31954354
https://pubmed.ncbi.nlm.nih.gov/31954354
Autor:
Sygkliti-Henrietta Pelidou, Konstantina G. Yiannopoulou, Aikaterini I. Anastasiou, Venetia Zachariou
Publikováno v:
Biomedicines
Despite all scientific efforts and many protracted and expensive clinical trials, no new drug has been approved by FDA for treatment of Alzheimer disease (AD) since 2003. Indeed, more than 200 investigational programs have failed or have been abandon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::209939a72e5963f547146db04d8ad0ee
https://doi.org/10.20944/preprints201909.0270.v1
https://doi.org/10.20944/preprints201909.0270.v1
Autor:
Sygkliti-Henrietta Pelidou
Publikováno v:
Open Access Journal of Neurology & Neurosurgery. 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8912eb84025ca1790e93b321fc7a9ca3
https://doi.org/10.19080/oajnn.2019.11.555813
https://doi.org/10.19080/oajnn.2019.11.555813
Autor:
Katerina E. Aifantis, Sanjiv Shrivastava, Sygkliti Henrietta Pelidou, Alfonso H.W. Ngan, Stavros J. Baloyannis
Publikováno v:
Biomaterials science. 7(6)
The blood thinning properties of pentoxifylline have been attributed to its ability to increase the deformability of red blood cells and improve their rheological properties. To interpret and substantiate these observations a novel approach is taken
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a74afacbdf763f2fd06eae33fcfc4be
https://pubmed.ncbi.nlm.nih.gov/30973560
https://pubmed.ncbi.nlm.nih.gov/30973560